{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:28:52Z","timestamp":1790011732252,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13346-020-00798-1","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T16:23:11Z","timestamp":1592929391000},"page":"318-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mucoadhesive bilayered buccal platform for antifungal drug delivery into the oral cavity"],"prefix":"10.1007","volume":"11","author":[{"given":"Burcum","family":"Uzuno\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Sa\u011f\u0131ro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevda","family":"\u015eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"issue":"5","key":"798_CR1","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.4317\/jced.51798","volume":"6","author":"C Garcia-Cuesta","year":"2014","unstructured":"Garcia-Cuesta C, Sarrion-Perez M, Bagan J. Current treatment of oral candidiasis: a literature review. J Clin Exp Dent. 2014;6(5):e576\u2013e82.","journal-title":"J Clin Exp Dent"},{"issue":"2","key":"798_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cden.2016.12.004","volume":"61","author":"DR Telles","year":"2017","unstructured":"Telles DR, Karki N, Marshall MW. Oral fungal infections: diagnosis and management. Dent Clin N Am. 2017;61(2):319\u201349.","journal-title":"Dent Clin N Am"},{"key":"798_CR3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3389\/fmicb.2015.01391","volume":"6","author":"S Patil","year":"2015","unstructured":"Patil S, Rao RS, Majumdar B, et al. Clinical appearance of oral candida infection and therapeutic strategies. Front Microbiol. 2015;6:1391.","journal-title":"Front Microbiol"},{"issue":"2","key":"798_CR4","first-page":"e172","volume":"24","author":"G Quind\u00f3s","year":"2019","unstructured":"Quind\u00f3s G, Gil-Alonso S, Marcos-Arias C, et al. Therapeutic tools for oral candidiasis: current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019;24(2):e172\u2013e80.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"798_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4899-7558-4_2","volume-title":"Oral mucosal drug delivery and therapy","author":"MJ Rathbone","year":"2015","unstructured":"Rathbone MJ, Pather I, \u015eenel S. Overview of oral mucosal delivery. In: Rathbone MJ, Senel S, Pather I, editors. Oral mucosal drug delivery and therapy. Boston: Springer US; 2015. p. 17\u201329."},{"issue":"2","key":"798_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/2230-973X.177826","volume":"6","author":"K Pathak","year":"2016","unstructured":"Pathak K, Sharma V, Akhtar N, Rastogi P. Localization of fluconazole in oral cavity by preferential coating of buccoadhesive tablet for treatment of oral thrush. Int J Pharm Investig. 2016;6(2):106\u201315.","journal-title":"Int J Pharm Investig"},{"issue":"1","key":"798_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2014.949235","volume":"12","author":"J-B Park","year":"2015","unstructured":"Park J-B, Prodduturi S, Morott J, Kulkarni VI, Jacob MR, Khan SI, et al. Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin on Drug Del. 2015;12(1):1\u201313.","journal-title":"Expert Opin on Drug Del"},{"issue":"5","key":"798_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajps.2016.05.004","volume":"11","author":"S Karki","year":"2016","unstructured":"Karki S, Kim H, Na S-J, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharm Sci. 2016;11(5):559\u201374.","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"798_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(99)00334-8","volume":"193","author":"S Senel","year":"2000","unstructured":"Senel S, Ikinci G, Kas S, et al. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm. 2000;193(2):197\u2013203.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"798_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2003.10.040","volume":"277","author":"G Ikinci","year":"2004","unstructured":"Ikinci G, \u015eenel S, Wilson CG, et al. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int J Pharm. 2004;277(1\u20132):173\u20138.","journal-title":"Int J Pharm"},{"issue":"11","key":"798_CR11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.addr.2005.07.003","volume":"57","author":"N Salamatmiller","year":"2005","unstructured":"Salamatmiller N, Chittchang M, Johnston T. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666\u201391.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"798_CR12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/17425247.5.5.531","volume":"5","author":"SI Pather","year":"2008","unstructured":"Pather SI, Rathbone MJ, Senel S. Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv. 2008;5(5):531\u201342.","journal-title":"Expert Opin Drug Deliv"},{"issue":"34","key":"798_CR13","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.2174\/138161212803307545","volume":"18","author":"J Bagan","year":"2012","unstructured":"Bagan J, Paderni C, Termine N, et al. Mucoadhesive polymers for oral transmucosal drug delivery: a review. Curr Pharm Des. 2012;18(34):5497\u2013514.","journal-title":"Curr Pharm Des"},{"key":"798_CR14","volume-title":"Oral mucosal drug delivery and therapy. Advances in delivery science and technology","author":"G Sandri","year":"2015","unstructured":"Sandri G, Rossi S, Ferrari F, et al. Mucoadhesive polymers as enabling excipients for oral mucosal drug delivery. In: Rathbone M, \u015eenel S, Pather I, editors. Oral mucosal drug delivery and therapy. Advances in delivery science and technology. Boston: Springer; 2015."},{"issue":"1\u20132","key":"798_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(01)00974-7","volume":"235","author":"G \u0130kinci","year":"2002","unstructured":"\u0130kinci G, \u015eenel S, Ak\u0131nc\u0131bay H, Ka\u015f S, Erci\u015f S, Wilson CG, et al. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm. 2002;235(1\u20132):121\u20137.","journal-title":"Int J Pharm"},{"issue":"2","key":"798_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2004.05.002","volume":"98","author":"P Aksungur","year":"2004","unstructured":"Aksungur P, Sungur A, \u00dcnal S, \u0130skit AB, Squier CA, \u015eenel S. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Control Release. 2004;98(2):269\u201379.","journal-title":"J Control Release"},{"issue":"5","key":"798_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4155\/tde.15.5","volume":"6","author":"S Nguyen","year":"2015","unstructured":"Nguyen S, Hiorth M. Advanced drug delivery systems for local treatment of the oral cavity. Ther Deliv. 2015;6(5):595\u2013608.","journal-title":"Ther Deliv"},{"key":"798_CR18","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s12325-017-0585-9","volume":"34","author":"B Vasseur","year":"2017","unstructured":"Vasseur B, Dufour A, Houdas L, Goodwin H, Harries K, Emul NY, et al. Comparison of the systemic and local pharmacokinetics of clonidine mucoadhesive buccal tablets with reference clonidine oral tablets in healthy volunteers: an open-label randomised cross-over trial. Adv Ther. 2017;34:2022\u201332.","journal-title":"Adv Ther"},{"key":"798_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2019.01.029","volume":"559","author":"SS Timur","year":"2019","unstructured":"Timur SS, Y\u00fcksel S, Akca G, \u015eenel S. Localized drug delivery with mono and bilayered mucoadhesive films and wafers for oral mucosal infections. Int J Pharm. 2019;559:102\u201312.","journal-title":"Int J Pharm"},{"issue":"6","key":"798_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-302X.2005.00236.x","volume":"20","author":"T Kuriyama","year":"2005","unstructured":"Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MAO. In vitro susceptibility of oral candida to seven antifungal agents. Oral Microbiol Immunol. 2005;20(6):349\u201353.","journal-title":"Oral Microbiol Immunol"},{"issue":"1","key":"798_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1601-5037.2008.00357.x","volume":"8","author":"Y Martinez-Beneyto","year":"2010","unstructured":"Martinez-Beneyto Y, Lopez-Jornet P, Velandrino-Nicolas A, et al. Use of antifungal agents for oral candidiasis: results of a national survey. Int J Dent Hyg. 2010;8(1):47\u201352.","journal-title":"Int J Dent Hyg"},{"issue":"5","key":"798_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5114\/pdia.2013.38358","volume":"30","author":"M Bondaryk","year":"2013","unstructured":"Bondaryk M, Kurz\u0105tkowski W, Staniszewska M. Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: mode of action and resistance development. Adv Dermatol Allergol. 2013;30(5):293\u2013301.","journal-title":"Adv Dermatol Allergol"},{"key":"798_CR23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/B978-0-12-386882-4.00038-4","volume-title":"Handbook of pharmacogenomics and stratified medicine","author":"HR Ashbee","year":"2014","unstructured":"Ashbee HR, Gilleece MH. Pharmacogenomics of antifungal agents. In: Padmanabhan S, editor. Handbook of pharmacogenomics and stratified medicine. San Diego: Academic Press; 2014. p. 879\u2013900."},{"issue":"6","key":"798_CR24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2015.02.011","volume":"45","author":"AAH Dalhoff","year":"2015","unstructured":"Dalhoff AAH, Levy SB. Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. Int J Antimicrob Agents. 2015;45(6):564\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"798_CR25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.0960-7439.2001.00310.x","volume":"11","author":"ST McDonnell","year":"2001","unstructured":"McDonnell ST, Hector MP. The distribution of stimulated saliva in children. Int J Paediatr Dent. 2001;11(6):417\u201323.","journal-title":"Int J Paediatr Dent"},{"issue":"4","key":"798_CR26","first-page":"443","volume":"51","author":"Y \u00c7apan","year":"1989","unstructured":"\u00c7apan Y, \u015eenel S, \u00c7al\u0131\u015f S, et al. Formulation and in vitro\/in vivo evaluation on sustained release acetylsalicylic acid tablets. Pharm Ind. 1989;51(4):443\u20138.","journal-title":"Pharm Ind"},{"issue":"11","key":"798_CR27","first-page":"792","volume":"46","author":"S \u015eenel","year":"1991","unstructured":"\u015eenel S, \u00c7apan Y, H\u0131ncal AA. Factors affecting the formulation of sustained release potassium chloride tablets. Pharmazie. 1991;46(11):792\u20135.","journal-title":"Pharmazie."},{"issue":"2","key":"798_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"798_CR29","first-page":"203","volume":"61","author":"G \u0130kinci","year":"2006","unstructured":"\u0130kinci G, \u015eenel S, Tokg\u00f6zo\u011flu L, et al. Development and in vitro\/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy. Pharmazie. 2006;61(3):203\u20137.","journal-title":"Pharmazie."},{"issue":"1","key":"798_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335.","journal-title":"Int J Pharm"},{"issue":"1","key":"798_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5(1):23\u201336.","journal-title":"J Control Release"},{"issue":"1","key":"798_CR32","first-page":"157","volume":"34","author":"N Azeran","year":"2017","unstructured":"Azeran N, Zazali N, Timur S, et al. Moxifloxacin loaded chitosan gel formulations for the treatment of periodontal diseases. J Polym Mater. 2017;34(1):157\u201369.","journal-title":"J Polym Mater"},{"key":"798_CR33","unstructured":"Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd ed., M27-A3. Clinical and Laboratory Standards Institute, Wayne, 2008."},{"issue":"2\u20133","key":"798_CR34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","volume":"48","author":"J Siepmann","year":"2001","unstructured":"Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2\u20133):139\u201357.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"798_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(00)00426-9","volume":"202","author":"T Ishikawa","year":"2000","unstructured":"Ishikawa T, Watanabe Y, Takayama K, Endo H, Matsumoto M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm. 2000;202(1\u20132):173\u20138.","journal-title":"Int J Pharm"},{"issue":"4","key":"798_CR36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/s1984-82502016000400020","volume":"52","author":"WL Guerra-Ponce","year":"2016","unstructured":"Guerra-Ponce WL, Gracia-V\u00e1squez SL, Gonz\u00e1lez-Barranco P, Camacho-Mora IA, Gracia-V\u00e1squez YA, Orozco-Beltr\u00e1n E, et al. In vitro evaluation of sustained released matrix tablets containing ibuprofen: a model poorly water-soluble drug. Braz J Pharm. 2016;52(4):751\u20139.","journal-title":"Braz J Pharm"},{"issue":"12","key":"798_CR37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","volume":"52","author":"T Higuchi","year":"1963","unstructured":"Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52(12):1145\u20139.","journal-title":"J Pharm Sci"},{"issue":"1","key":"798_CR38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.03.051","volume":"418","author":"J Siepmann","year":"2011","unstructured":"Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418(1):6\u201312.","journal-title":"Int J Pharm"},{"issue":"4","key":"798_CR39","first-page":"110","volume":"60","author":"NA Peppas","year":"1985","unstructured":"Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110\u20131.","journal-title":"Pharm Acta Helv"},{"issue":"1","key":"798_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1567201052772906","volume":"2","author":"M Grassi","year":"2005","unstructured":"Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv. 2005;2(1):97\u2013116.","journal-title":"Curr Drug Deliv"},{"issue":"3","key":"798_CR41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1248\/cpb.43.483","volume":"43","author":"G Xu","year":"1995","unstructured":"Xu G, Sunada H. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Chem Pharm Bull. 1995;43(3):483\u20137.","journal-title":"Chem Pharm Bull"},{"issue":"2\u20133","key":"798_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-3659(97)00099-0","volume":"51","author":"S \u015eenel","year":"1998","unstructured":"\u015eenel S, Duch\u00eane D, H\u0131ncal AA, \u00c7apan Y, Ponchel G. In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride. J Control Release. 1998;51(2\u20133):107\u201313.","journal-title":"J Control Release"},{"issue":"8","key":"798_CR43","first-page":"377","volume":"4","author":"MV Velasco","year":"1998","unstructured":"Velasco MV, Ford JL, Rajabi-Siahboomi AR. Effect of media on the dissolution profiles of propranolol hydrochloride from matrices containing different substitution types of Methocel. Pharm Pharmacol Commun. 1998;4(8):377\u201383.","journal-title":"Pharm Pharmacol Commun"},{"issue":"2","key":"798_CR44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/mp500563n","volume":"12","author":"D Caccavo","year":"2015","unstructured":"Caccavo D, Cascone S, Lamberti G, Barba AA. Modeling the drug release from hydrogel-based matrices. Mol Pharm. 2015;12(2):474\u201383.","journal-title":"Mol Pharm"},{"issue":"9","key":"798_CR45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0003-9969(85)90158-X","volume":"30","author":"GN Jenkins","year":"1985","unstructured":"Jenkins GN, Krebsbach PH. Experimental study of the migration of charcoal particles in the human mouth. Arch Oral Biol. 1985;30(9):697\u20139.","journal-title":"Arch Oral Biol"},{"issue":"9","key":"798_CR46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0003-9969(92)90083-K","volume":"37","author":"MP Hector","year":"1992","unstructured":"Hector MP, Sullivan A. Migration of erythrosin-labelled saliva during unilateral chewing in man. Arch Oral Biol. 1992;37(9):757\u20138.","journal-title":"Arch Oral Biol"},{"key":"798_CR47","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1208\/pt0802034","volume":"8","author":"TP De Souza","year":"2007","unstructured":"De Souza TP, Mart\u00ednez-Pacheco R, G\u00f3mez-Amoza JL, et al. Eudragit E as excipient for production of granules and tablets from phyllanthus niruri L spray-dried extract. AAPS PharmSciTech. 2007;8:E54\u201360.","journal-title":"AAPS PharmSciTech"},{"key":"798_CR48","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1208\/pt0803054","volume":"8","author":"L Perioli","year":"2007","unstructured":"Perioli L, Ambrogi V, Giovagnoli S, Ricci M, Blasi P, Rossi C. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAPS PharmSciTech. 2007;8:E20\u2013E7.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"798_CR49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2230-973X.96924","volume":"2","author":"S Shirsand","year":"2012","unstructured":"Shirsand S, Suresh S, Keshavshetti G, et al. Formulation and optimization of mucoadhesive bilayer buccal tablets of atenolol using simplex design method. Int J Pharm Investig. 2012;2(1):34\u201341.","journal-title":"Int J Pharm Investig."},{"issue":"2","key":"798_CR50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/02652048.2011.630109","volume":"29","author":"P Yedurkar","year":"2012","unstructured":"Yedurkar P, Dhiman MK, Petkar K, Sawant K. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres:in vitro, pharmacokinetic and pharmacodynamic investigations. J Microencapsul. 2012;29(2):126\u201337.","journal-title":"J Microencapsul"},{"issue":"1","key":"798_CR51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10717544.2011.644348","volume":"19","author":"SK Maurya","year":"2012","unstructured":"Maurya SK, Bali V, Pathak K. Bilayered transmucosal drug delivery system of pravastatin sodium: statistical optimization, in vitro, ex vivo, in vivo and stability assessment. Drug Deliv. 2012;19(1):45\u201357.","journal-title":"Drug Deliv"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-020-00798-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T01:10:15Z","timestamp":1624410615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-020-00798-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00798-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"23 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}